Recursion is seeking a Director, CMC Regulatory Affairs to lead the global CMC strategy for small molecule investigational drugs, guiding Phase 1-3 development and marketing submissions (Module 2, Module 3, IMPD) for US, EU and ROW. You’ll manage internal and external contributors, deliver high quality INDs and amendments, and advise on risk mitigation amid evolving GMP regulations. The ideal candidate has 8+ years in CMC regulatory, deep technical knowledge of drug substance and product, a relevant degree (RAC preferred), and a proven track record of cross-functional leadership and regulatory submissions. Remote-friendly with occasional travel; base £111,100-£141,800, plus bonus, equity and benefits. Apply directly via Recursion’s careers page; agency resumes are not accepted unless invited.
The Impact You’ll Make
The Team You’ll Join
As Director CMC Regulatory Affairs, you will be an essential member of the Recursion Development Team, reporting to the Vice President of Regulatory Affairs. The Development Team is an empowered, execution-minded group of development, manufacturing and clinical development professionals responsible for translating Recursion’s innovative science to patients through clinical and business development activities.
The Experience You’ll Need
Working Location & Compensation:
This role is remote-friendly, with most work conducted from home. There may be occasional opportunities or expectations for travel to our Salt Lake City headquarters or other office locations.
At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is: £111,100—£141,800. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.
#LI-REMOTE
#LI-ES1
The Values We Hope You Share:
Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.
More About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.